Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 54 results

research The Effect of Treatment with an LH-RH Agonist (Buserelin) on Gonadal Activity, Growth, and Bone Maturation in Children with Central Precocious Puberty

34 citations , May 1987 in “European Journal of Pediatrics”

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

research Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism

3 citations , July 2009 in “Experimental and Clinical Endocrinology & Diabetes”

17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Reveal Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome

research 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Reveal Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome

42 citations , September 2007 in “The Journal of Clinical Endocrinology and Metabolism”

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome

4809 citations , January 2004 in “Fertility and Sterility”

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations , December 2003 in “Human Reproduction”

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

View more "buserelin" in research →

Community Join

0 / 0 results

— no results